S&P 500   3,295.47 (-0.90%)
DOW   28,989.73 (-0.58%)
QQQ   222.70 (-0.84%)
AAPL   318.31 (-0.29%)
FB   217.95 (-0.82%)
MSFT   165.04 (-1.01%)
GOOGL   1,466.17 (-1.25%)
AMZN   1,861.64 (-1.22%)
CGC   22.65 (-7.78%)
NVDA   250.48 (-0.94%)
BABA   213.75 (-2.46%)
MU   57.76 (-2.43%)
GE   11.71 (-0.51%)
TSLA   564.82 (-1.29%)
AMD   50.35 (-2.63%)
T   38.50 (-0.34%)
ACB   1.99 (-3.86%)
F   9.00 (-1.53%)
NFLX   353.16 (+1.02%)
PRI   122.53 (-2.41%)
BAC   33.54 (-1.70%)
DIS   140.08 (-1.49%)
GILD   63.15 (-1.24%)
S&P 500   3,295.47 (-0.90%)
DOW   28,989.73 (-0.58%)
QQQ   222.70 (-0.84%)
AAPL   318.31 (-0.29%)
FB   217.95 (-0.82%)
MSFT   165.04 (-1.01%)
GOOGL   1,466.17 (-1.25%)
AMZN   1,861.64 (-1.22%)
CGC   22.65 (-7.78%)
NVDA   250.48 (-0.94%)
BABA   213.75 (-2.46%)
MU   57.76 (-2.43%)
GE   11.71 (-0.51%)
TSLA   564.82 (-1.29%)
AMD   50.35 (-2.63%)
T   38.50 (-0.34%)
ACB   1.99 (-3.86%)
F   9.00 (-1.53%)
NFLX   353.16 (+1.02%)
PRI   122.53 (-2.41%)
BAC   33.54 (-1.70%)
DIS   140.08 (-1.49%)
GILD   63.15 (-1.24%)
S&P 500   3,295.47 (-0.90%)
DOW   28,989.73 (-0.58%)
QQQ   222.70 (-0.84%)
AAPL   318.31 (-0.29%)
FB   217.95 (-0.82%)
MSFT   165.04 (-1.01%)
GOOGL   1,466.17 (-1.25%)
AMZN   1,861.64 (-1.22%)
CGC   22.65 (-7.78%)
NVDA   250.48 (-0.94%)
BABA   213.75 (-2.46%)
MU   57.76 (-2.43%)
GE   11.71 (-0.51%)
TSLA   564.82 (-1.29%)
AMD   50.35 (-2.63%)
T   38.50 (-0.34%)
ACB   1.99 (-3.86%)
F   9.00 (-1.53%)
NFLX   353.16 (+1.02%)
PRI   122.53 (-2.41%)
BAC   33.54 (-1.70%)
DIS   140.08 (-1.49%)
GILD   63.15 (-1.24%)
S&P 500   3,295.47 (-0.90%)
DOW   28,989.73 (-0.58%)
QQQ   222.70 (-0.84%)
AAPL   318.31 (-0.29%)
FB   217.95 (-0.82%)
MSFT   165.04 (-1.01%)
GOOGL   1,466.17 (-1.25%)
AMZN   1,861.64 (-1.22%)
CGC   22.65 (-7.78%)
NVDA   250.48 (-0.94%)
BABA   213.75 (-2.46%)
MU   57.76 (-2.43%)
GE   11.71 (-0.51%)
TSLA   564.82 (-1.29%)
AMD   50.35 (-2.63%)
T   38.50 (-0.34%)
ACB   1.99 (-3.86%)
F   9.00 (-1.53%)
NFLX   353.16 (+1.02%)
PRI   122.53 (-2.41%)
BAC   33.54 (-1.70%)
DIS   140.08 (-1.49%)
GILD   63.15 (-1.24%)
Log in

ASX:CD1 - US Select Private Opportunities Fund Stock Price, Forecast & News

Add
Today's Range N/A
50-Day Range
A$1.54
MA: A$1.56
A$1.63
52-Week Range N/A
Volume1,633 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
US Select Private Opportunities Fund, LP is a co-sponsored fund of Cordish Private Ventures LLC and Dixon Advisory and Superannuation Services Pty Ltd., Investment Arm. It specializes in fund of fund investments in buyout funds focused on small to lower middle-markets in the United States.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
CUSIPN/A
CIKN/A
Phone1300 852 017

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive CD1 News and Ratings via Email

Sign-up to receive the latest news and ratings for CD1 and its competitors with MarketBeat's FREE daily newsletter.


US Select Private Opportunities Fund (ASX:CD1) Frequently Asked Questions

What is US Select Private Opportunities Fund's stock symbol?

US Select Private Opportunities Fund trades on the ASX under the ticker symbol "CD1."

How often does US Select Private Opportunities Fund pay dividends? What is the dividend yield for US Select Private Opportunities Fund?

US Select Private Opportunities Fund declared a Interim dividend on Friday, July 26th. Shareholders of record on Wednesday, August 14th will be given a dividend of 0.25 per share on Wednesday, August 14th. This represents a yield of 12.56%. The ex-dividend date of this dividend is Tuesday, July 30th. This is a positive change from US Select Private Opportunities Fund's previous Interim dividend of $0.08. View US Select Private Opportunities Fund's Dividend History.

Has US Select Private Opportunities Fund been receiving favorable news coverage?

News articles about CD1 stock have trended very positive recently, InfoTrie Sentiment reports. The research group ranks the sentiment of press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. US Select Private Opportunities Fund earned a news sentiment score of 4.0 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the next few days. View News Stories for US Select Private Opportunities Fund.

Who are US Select Private Opportunities Fund's key executives?

US Select Private Opportunities Fund's management team includes the folowing people:
  • Mr. Daryl Albert Dixon, Exec. Chairman of Dixon Advisory & Superannuation Services Limited
  • Mr. Tristan Aloysius O'Connell BComm (ANU), CPA, F Fin, Fin. Director, Sec. & Director of Dixon Advisory & Superannuation Svcs Ltd
  • Mr. Christopher Matthew Brown, COO, MD & Director of Dixon Advisory & Superannuation Services Limited
  • Mr. Alan Cochrane Dixon BCom. (ANU), CA, Group MD & Director of Dixon Advisory & Superannuation Svcs Ltd
  • Mr. Alexander Gen MacLachlan Ba (Cornell), Mba (Wharton), MD, Director & CEO of Funds Mgmt of Dixon Advisory & Superannuation Svcs Ltd

What is US Select Private Opportunities Fund's official website?

The official website for US Select Private Opportunities Fund is http://www.cordishdixonfunds.com.au/.

How can I contact US Select Private Opportunities Fund?

The company can be reached via phone at 1300 852 017.


MarketBeat Community Rating for US Select Private Opportunities Fund (ASX CD1)

Community Ranking:  1.5 out of 5 (star half star)
Outperform Votes:  6 (Vote Outperform)
Underperform Votes:  14 (Vote Underperform)
Total Votes:  20
MarketBeat's community ratings are surveys of what our community members think about US Select Private Opportunities Fund and other stocks. Vote "Outperform" if you believe CD1 will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CD1 will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel